Jan H Loeb
CIK 1131043 · President and CEO · last filed 2026-01-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ACFN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
10451 MILL RUN CIRCLE SUITE 400
OWINGS MILLS, MD 21117
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACFN | President and CEO | 515,449 | $17.12 | $8.82M | $1.73M | 31 | 2026-01-21 |
| GYRO | Director | 69,218 | $4.42 | $305.9K | $0 | 1 | 2024-03-14 |
| KID BRANDS, INC (KID) Delisted | Director | 2,073,118 | — | — | $0 | 2 | 2014-02-06 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Director | 44,855 | — | — | $0 | 2 | 2011-06-21 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (GTA) Delisted | Director | — | — | — | $0 | 2 | 2010-01-19 |
Recent Filings · Page 3 of 5
50 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-07-01 | ACFN | Buy (P) | +5,409,062 | $1.30M | EDGAR |
| 2019-06-26 | ACFN | Exer (X) | +461,589 | $110.8K | EDGAR |
| 2018-12-18 | ACFN | Buy (P) | +191,280 | $49.9K | EDGAR |
| 2018-05-02 | ACFN | Grant (A) | — | $0 | EDGAR |
| 2018-04-02 | ACFN | Buy (P) | +105,000 | $31.5K | EDGAR |
| 2018-03-29 | ACFN | Buy (P) | +126,694 | $38.0K | EDGAR |
| 2017-02-23 | ACFN | Grant (A) | — | $0 | EDGAR |
| 2016-07-25 | ACFN | Buy (P) | +93,637 | $14.0K | EDGAR |
| 2016-06-27 | ACFN | Other (J) | −287,157 | $0 | EDGAR |
| 2016-05-16 | ACFN | Buy (P) | +400,000 | $60.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.